Chugai Pharmaceutical Co., Ltd. (CHGCY)
20.75
0.00 (0.00%)
USD |
OTCM |
Sep 14, 16:00
Chugai Pharmaceutical Price to Book Value : 5.473 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 5.473 |
| September 11, 2026 | 5.473 |
| September 10, 2026 | 5.410 |
| September 09, 2026 | 5.515 |
| September 08, 2026 | 5.552 |
| September 04, 2026 | 5.694 |
| September 03, 2026 | 5.80 |
| September 02, 2026 | 5.689 |
| September 01, 2026 | 5.666 |
| August 31, 2026 | 5.684 |
| August 28, 2026 | 5.755 |
| August 27, 2026 | 5.713 |
| August 26, 2026 | 5.768 |
| August 25, 2026 | 5.763 |
| August 24, 2026 | 5.755 |
| August 21, 2026 | 5.853 |
| August 20, 2026 | 5.826 |
| August 19, 2026 | 5.829 |
| August 18, 2026 | 5.663 |
| August 17, 2026 | 5.658 |
| August 14, 2026 | 5.684 |
| August 13, 2026 | 5.913 |
| August 12, 2026 | 5.966 |
| August 11, 2026 | 5.858 |
| August 10, 2026 | 5.861 |
| Date | Value |
|---|---|
| August 07, 2026 | 5.713 |
| August 06, 2026 | 5.549 |
| August 05, 2026 | 5.512 |
| August 04, 2026 | 5.592 |
| August 03, 2026 | 5.576 |
| July 31, 2026 | 5.700 |
| July 30, 2026 | 5.842 |
| July 29, 2026 | 5.650 |
| July 28, 2026 | 5.659 |
| July 27, 2026 | 5.520 |
| July 24, 2026 | 5.768 |
| July 23, 2026 | 5.832 |
| July 22, 2026 | 5.895 |
| July 21, 2026 | 6.024 |
| July 20, 2026 | 5.953 |
| July 17, 2026 | 5.964 |
| July 16, 2026 | 5.882 |
| July 15, 2026 | 5.755 |
| July 14, 2026 | 5.887 |
| July 13, 2026 | 5.892 |
| July 10, 2026 | 6.035 |
| July 09, 2026 | 6.022 |
| July 08, 2026 | 5.948 |
| July 07, 2026 | 6.193 |
| July 06, 2026 | 6.135 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.264 |
| Daiichi Sankyo Co., Ltd. | 3.197 |
| Eisai Co., Ltd. | 1.552 |
| Santen Pharmaceutical Co., Ltd. | 1.944 |
| Ono Pharmaceutical Co., Ltd. | 1.325 |
Price to Book Value Related Metrics
| PE Ratio | 22.37 |
| PS Ratio | 7.849 |
| PEG Ratio | 1.447 |
| Price to Free Cash Flow | 27.93 |
| Price | 20.75 |
| Earnings Yield | 4.47% |
| Market Cap | 68.28B |
| PEGY Ratio | 1.447 |
| Operating PE Ratio | 15.56 |
| Normalized PE Ratio | 21.36 |